long-awaited landmark hypertension study will shake things up
January 2003
The surprising results from the long-awaited landmark hypertension study will shake things up.
Canadian guidelines currently recommend a diuretic, ACE inhibitor, calcium channel blocker, or beta-blocker for initial treatment of high blood pressure.
Now the huge ALLHAT study suggests that a diuretic is often a better first choice than the others.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive